Pierre Beaurang

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
San Francisco, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Christine Ring, as Attorney-in-Fact for Pierre Beaurang
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Pierre Beaurang

Form 4 holding Chief Business Officer

Nurix Therapeutics, Inc.

Security class
Common Stock
Shares / value
116,666
Estimated value
$1,167,022
Report date
10 Aug 2021
Price
$10.00
Ownership
By Trust
Form 4 holding Chief Business Officer

Nurix Therapeutics, Inc.

Security class
Common Stock
Shares / value
4,330
Estimated value
$43,313
Report date
10 Aug 2021
Price
$10.00
Ownership
Direct
Form 4 holding Chief Business Officer

Nurix Therapeutics, Inc.

Security class
Employee Stock Option (right to buy)
Shares / value
6,562
Estimated value
Report date
10 Aug 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Pierre Beaurang

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .